Part 1. Definition
In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Part 2. Example
SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Answer: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Explanation: This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.
Part 3. Exercise
SECTION 1. SHORT TITLE.

This Act may be cited as the ''Club Drug Anti-Proliferation Act of
2000''.

SEC. 2. FINDINGS.

Congress makes the following findings:
(1) The illegal importation of 3,4-
methylenedioxymethamphetamine, commonly referred to as ''MDMA''
or ''Ecstasy'', and paramethoxyamphetamine, commonly referred
to as ''PMA'', have increased in recent years, as evidenced by
the fact that club drug seizures by the United States Customs
Service have risen from less than 500,000 tablets during fiscal
year 1997 to more than 4,000,000 tablets during the first 5
months of fiscal year 2000.
(2) Use of club drugs can cause long-lasting, and perhaps
permanent, damage to the serotonin system of the brain, which
is fundamental to the integration of information and emotion,
and this damage can cause long-term problems with learning and
memory.
(3) Due to the popularity and marketability of club drugs,
there are numerous Internet websites with information on its
effects, production, and the locations of use, often referred
to as ''raves''. The availability of this information targets
the primary users of club drugs, who are most often college
students, young professionals, and other young people from
middle- to high-income families.
(4) Greater emphasis needs to be placed on--
(A) penalties associated with the manufacture,
distribution, and use of club drugs;
(B) the education of young people on the negative
health effects of club drugs, since the reputation of
club drugs as ''safe'' drugs is its most dangerous
component;
(C) the education of State and local law
enforcement agencies regarding the growing problem of
club drug trafficking across the United States;
(D) reducing the number of deaths caused by club
drug use and its combined use with alcohol; and
(E) adequate funding for research by the National
Institute on Drug Abuse to--
(i) identify those most vulnerable to using
club drugs and develop science-based prevention
approaches tailored to the specific needs of
individuals at high risk;
(ii) understand how club drugs produce its
toxic effects and how to reverse neurotoxic
damage;
(iii) develop treatments, including new
medications and behavioral treatment
approaches;
(iv) better understand the effects that
club drugs have on the developing children and
adolescents; and
(v) translate research findings into useful
tools and ensure their effective dissemination.

SEC. 3. ENHANCED PUNISHMENT OF CLUB DRUG TRAFFICKERS.

(a) Amendment to Federal Sentencing Guidelines.--Pursuant to its
authority under section 994(p) of title 28, United States Code, the
United States Sentencing Commission shall amend the Federal sentencing
guidelines regarding any offense relating to the manufacture,
importation, or exportation of, or trafficking in--
(1) 3,4-methylenedioxy methamphetamine;
(2) 3,4-methylenedioxy amphetamine;
(3) 3,4-methylenedioxy-N-ethylamphetamine;
(4) paramethoxymethamphetamine (PMA); or
(5) any other controlled substance, as determined by the
Sentencing Commission in consultation with the Attorney
General, that is marketed as a club drug and that has either a
chemical structure substantially similar to that of 3,4-
methylenedioxy methamphetamine or paramethoxymethamphetamine or
an effect on the central nervous system substantially similar
to or greater than that of 3,4-methylenedioxy methamphetamine
or paramethoxymethamphetamine; (including an attempt or
conspiracy to commit an offense described in paragraph (1),
(2), (3), or (4)) in violation of the Controlled Substances Act
(21 U.S.C. 801 et seq.), the Controlled Substances Import and
Export Act (21 U.S.C. 951 et seq.), or the Maritime Drug Law
Enforcement Act (46 U.S.C. 1901 et seq.).
(b) General Requirement.--In carrying out this section, the United
States Sentencing Commission shall, with respect to each offense
described in subsection (a)--
(1) review and amend the Federal sentencing guidelines to
provide for increased penalties such that those penalties are
comparable to the base offense levels for offenses involving
any methamphetamine mixture; and
(2) take any other action the Commission considers to be
necessary to carry out this subsection.
(c) Additional Requirements.--In carrying out this section, the
United States Sentencing Commission shall ensure that the Federal
Sentencing guidelines for offenders convicted of offenses described in
subsection (a) reflect--
(1) the need for aggressive law enforcement action with
respect to offenses involving the controlled substances
described in subsection (a); and
(2) the dangers associated with unlawful activity involving
such substances, including--
(A) the rapidly growing incidence of abuse of the
controlled substances described in subsection (a) and
the threat to public safety that such abuse poses;
(B) the recent increase in the illegal importation
of the controlled substances described in subsection
(a);
(C) the young age at which children are beginning
to use the controlled substances described in
subsection (a); and
(D) any other factor that the Sentencing Commission
deems appropriate.

SEC. 4. ENHANCED PUNISHMENT OF GHB TRAFFICKERS.

(a) Amendment to Federal Sentencing Guidelines.--Pursuant to its
authority under section 994(p) of title 28, United States Code, the
United States Sentencing Commission shall amend the Federal sentencing
guidelines in accordance with this section with respect to any offense
relating to the manufacture, importation, or exportation of, or
trafficking in--
(1) gamma-hydroxybutyric acid and its salts; or
(2) the List I Chemical gamma-butyrolactone; (including an
attempt or conspiracy to commit an offense described in
paragraph (1) or (2)) in violation of the Controlled Substances
Act (21 U.S.C. 801 et seq.), the Controlled Substances Import
and Export Act (21 U.S.C. 951 4 et seq.), or the Maritime Drug
Law Enforcement Act (46 5 U.S.C. 1901 et seq.).
(b) General Requirements.--In carrying out this section, the United
States Sentencing Commission shall with respect to each offense
described in subsection (a)--
(1) review and amend the Federal Sentencing guidelines to
provide for increased penalties such that those penalties
reflect the seriousness of these offenses and the need to deter
them;
(2) assure that the guidelines provide that offenses
involving a significant quantity of Schedule I and II
depressants are subject to greater terms of imprisonment than
currently provided by the guidelines and that such terms are
consistent with applicable statutory maximum penalties; and
(3) take any other action the Commission considers to be
necessary to carry out this subsection.
(c) Additional Requirements.--In carrying out this section, the
United States Sentencing Commission shall consider--
(1) the dangers associated with the use of the substances
described in subsection (a), and unlawful activity involving
such substances;
(2) the rapidly growing incidence of abuse of the
controlled substances described in subsection (a) and the
threat to public safety that such abuse poses, including the
dangers posed by overdose; and
(3) the recent increase in the illegal manufacture of the
controlled substances described in subsection (a).

SEC. 5. EMERGENCY AUTHORITY TO SENTENCING COMMISSION.

The United States Sentencing Commission shall promulgate amendments
under this Act as soon as practicable after the date of the enactment
of this Act in accordance with the procedure set forth in section 21(a)
of the Sentencing Act of 1987 (Public Law 100-182), as though the
authority under that Act had not expired.

SEC. 6. PROHIBITION ON DISTRIBUTION OF INFORMATION RELATING TO THE
MANUFACTURE OR ACQUISITION OF CONTROLLED SUBSTANCES.

Section 403 of the Controlled Substances Act (21 U.S.C. 843) is
amended by adding at the end the following:
''(g) Prohibition on Distribution of Information Relating to
Manufacture or Acquisition of Controlled Substances.--
''(1) Controlled substance defined.--In this subsection,
the term 'controlled substance' has the meaning given that term
in section 102(6) of the Controlled Substances Act (21 U.S.C.
802(6)).
''(2) Prohibition.--It shall be unlawful for any person--
''(A) to teach or demonstrate the manufacture of a
controlled substance, or to distribute by any means
information pertaining to, in whole or in part, the
manufacture, acquisition, or use of a controlled
substance, with the intent that the teaching,
demonstration, or information be used for, or in
furtherance of, an activity that constitutes a crime;
or
''(B) to teach or demonstrate to any person the
manufacture of a controlled substance, or to distribute
to any person, by any means, information pertaining to,
in whole or in part, the manufacture, acquisition, or
use of a controlled substance, knowing or having reason
to know that such person intends to use the teaching,
demonstration, or information for, or in furtherance
of, an activity that constitutes an offense.
''(3) Penalty.--Any person who violates this subsection
shall be fined under this title, imprisoned not more than 10
years, or both.''.

SEC. 7. ANTIDRUG MESSAGES ON FEDERAL GOVERNMENT INTERNET WEBSITES.

Not later than 90 days after the date of enactment of this Act, the
head of each department, agency, and establishment of the Federal
Government shall, in consultation with the Director of the Office
of National Drug Control Policy, place antidrug messages on appropriate
Internet websites controlled by such department, agency, or
establishment which messages shall, where appropriate, contain an
electronic hyperlink to the Internet website, if any, of the Office of
National Drug Control Policy.

SEC. 8. EXPANSION OF CLUB DRUG ABUSE PREVENTION EFFORTS.

(a) Public Health Service Assistance.--Part A of title V of the
Public Health Service Act (42 U.S.C. 20 290aa et seq.) is amended by
adding at the end the following:

''SEC. 506. GRANTS FOR CLUB DRUG ABUSE PREVENTION.

(a) Authority.--The Administrator may make grants to, and enter
into contracts and cooperative agreements with, public and nonprofit
private entities to enable such entities--
''(1) to carry out school-based programs concerning the
dangers of abuse of and addiction to 3,4-methylenedioxy
methamphetamine, paramethoxymethamphetamine or related drugs,
using methods that are effective and science-based, including
initiatives that give students the responsibility to create
their own antidrug abuse education programs for their schools;
and
''(2) to carry out community-based abuse and addiction
prevention programs relating to 3,4-methylenedioxy
methamphetamine, paramethoxymethamphetamine or related drugs
that are effective and science-based.
''(b) Use of Funds.--Amounts made available under a grant, contract
or cooperative agreement under subsection (a) shall be used for
planning, establishing, or administering prevention programs relating
to 3,4-methylenedioxy methamphetamine, paramethoxymethamphetamine or
related drugs in accordance with paragraph (3).
''(c)(1) Discretionary Functions.--Amounts provided under this
section may be used--
''(A) to carry out school-based programs that are focused
on those districts with high or increasing rates of abuse and
addiction to 3,4-methylenedioxy methamphetamine,
paramethoxymethamphetamine or related drugs and targeted at
populations that are most at risk to start abuse of 3,4-
methylenedioxy methamphetamine, paramethoxymethamphetamine or
related drugs;
''(B) to carry out community-based prevention programs that
are focused on those populations within the community that are
most at-risk for abuse of and addiction to 3,4-methylenedioxy
methamphetamine, paramethoxymethamphetamine or related drugs;
''(C) to assist local government entities to conduct
appropriate prevention activities relating to 3,4-
methylenedioxy methamphetamine, paramethoxymethamphetamine or
related drugs;
''(D) to train and educate State and local law enforcement
officials, prevention and education officials, health
professionals, members of community antidrug coalitions and
parents on the signs of abuse of and addiction to 3,4-
methylenedioxy methamphetamine, paramethoxymethamphetamine or
related drugs, and the options for treatment and prevention;
''(E) for planning, administration, and educational
activities related to the prevention of abuse of and addiction
to 3,4-methylenedioxy methamphetamine,
paramethoxymethamphetamine or related drugs;
''(F) for the monitoring and evaluation of prevention
activities relating to 3,4-methylenedioxy methamphetamine,
paramethoxymethamphetamine or related drugs, and reporting and
disseminating resulting information to the public; and
''(G) for targeted pilot programs with evaluation
components to encourage innovation and experimentation with new
methodologies.
''(2) Priority.--The Administrator shall give priority in making
grants under this subsection to rural and urban areas that are
experiencing a high rate or rapid increases in abuse and addiction to
3,4-methylenedioxy methamphetamine, paramethoxymethamphetamine or
related drugs.
''(d)(1) Prevention Program Allocation.--Not less than $500,000 of
the amount available in each fiscal year to carry out this section
shall be made available to the Administrator, acting in consultation
with other Federal agencies, to support and conduct periodic analyses
and evaluations of effective prevention programs for abuse of and
addiction to 3,4-methylenedioxy methamphetamine,
paramethoxymethamphetamine or related drugs and the development of
appropriate strategies for disseminating information about and
implementing these programs.
''(2) Report.--The Administrator shall submit an annual report
containing the results of the analyses and evaluations conducted under
paragraph (1) to--
''(A) the Committee on Health, Education, Labor, and
Pensions, the Committee on the Judiciary, and the Committee on
Appropriations of the Senate; and
''(B) the Committee on Commerce, the Committee on the
Judiciary, and the Committee on Appropriations of the House of
Representatives.
''(e) Authorization.--There is authorized to be appropriated to
carry out this subsection--
''(1) $5,000,000 for fiscal year 2001; and
''(2) such sums as may be necessary for each succeeding
fiscal year.''.
(b) National Youth Antidrug Media Campaign.--In conducting the
national media campaign under section 102 of the Drug-Free Media
Campaign Act of 1998 (21 U.S.C. 1801), the Director of the Office of
National Drug Control Policy shall ensure that such campaign addresses
the reduction and prevention of abuse of 3,4-methylenedioxy
methamphetamine, paramethoxymethamphetamine or related drugs among
young people in the United States.
Answer:
(Sec. 4) Sets forth similar provisions with respect to offenses relating to the manufacture, importation, or exportation of, or trafficking in, gamma-hydroxybutyric acid and its salts (GHB), or the List I chemical gamma-butyrolactone.
(Sec. 5) Directs the Commission to promulgate amendments under this Act as soon as practicable after this Act's enactment date in accordance with a procedure set forth in the Sentencing Act of 1987 (emergency guidelines promulgation authority), as though the authority under that Act had not expired.
(Sec. 6) Amends the CSA to prohibit any person from teaching, demonstrating, or distributing information pertaining to the manufacture of: (1) a controlled substance with the intent that the teaching, demonstration, or information be used for, or in furtherance of, an activity that constitutes a crime; or (2) a controlled substance to any person knowing that such person intends to use the teaching, demonstration, or information for, or in furtherance of, an activity that constitutes an offense. Sets penalties for violations.
(Sec. 7) Requires the head of each Federal department, agency, and establishment (department) to place anti-drug messages on appropriate Internet websites controlled by such department which shall contain an electronic hyperlink to the Internet website of the Office of National Drug Control Policy.
(Sec. 8) Amends the Public Health Service Act to authorize the Administrator of the Substance Abuse and Mental Health Services Administration to make grants to, and enter into contracts and cooperative agreements with, public and nonprofit private entities to carry out: (1) school-based programs concerning the dangers of abuse of and addiction to MDMA, PMA, or related drugs, using methods that are effective and science-based, including initiatives that give students the responsibility to create their own anti-drug abuse education programs for their schools; and (2) community-based abuse and addiction prevention programs relating to MDMA, PMA, or related drugs that are effective and science-based.
Sets forth provisions regarding: (1) permissible uses of grant funds; (2) priorities for grants; (3) a specified annual allocation to support and conduct periodic analyses and evaluations of effective prevention programs for abuse of and addiction to MDMA, PMA, or related drugs and the development of strategies for disseminating information about and implementing such programs; and (4) reporting requirements. Authorizes appropriations.
Requires the Director of the Office of National Drug Control Policy, in conducting the national media campaign under the Drug-Free Media Campaign Act of 1998, to ensure that such campaign addresses the reduction and prevention of abuse of MDMA, PMA, or related drugs among young people in the United States.